Childen's Hospital Boston                                                      

Quantitative Imaging Cytometry Center of Excellence

Quantitative Imaging Cytometry Symposium

Boston, Massachusetts

August 10 – 12, 2010

 Symposium Registration

MORNING SESSIONS

Tuesday, August 10, 2010

Quantitative Imaging Cytometry as a Cutting-Edge Research Tool

Enders Auditorium, Children's Hospital Boston

Chairs: Leslie Silberstein, Children's Hospital Boston and William Telford, NIH

08.00  –  9.00

Registration

09.00  –  9.15

Welcome – Leslie Silberstein, MD, Director, Joint Program in Transfusion Medicine, Children's Hospital Boston, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

09.15  –  9.55

Imaging Cytometry: An Expanding Role in Biomedical Imaging Analysis – William Telford, PhD, Director, Flow Cytometry Core Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD

09.55 – 10.35

Spatial Analysis of Hematopoietic Stem and Progenitor Cells in Bone Marrow – Leslie Silberstein, MD, Director, Joint Program in Transfusion Medicine, Children's Hospital Boston, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

10.35 – 10.45

Break

10.45 – 11.25

 

Combinatorial Development of Biomaterials for Tissue Engineering and Drug Delivery –
Daniel Anderson, PhD, Senior Research Associate, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA

11.25 – 12.05

The iCys Imaging Cytometer in the Epigenetic Toolbox for Autism Research - Janine  LaSalle, PhD, Professor, Medical Microbiology and Immunology, UC Davis School of Medicine, Davis, CA.

12.05 – 12.15

Discussion

Wednesday, August 11, 2010

Advanced Cell Cycle and DNA Damage Analysis

Jimmy Fund Auditorium, Dana-Farber Cancer Center

Chair: Michael Fenech, CSIRO, Adelaide, Australia

09.00 –  9.30

Assessment of DNA Damage by High-Resolution Cytometry – Zbigniew Darzynkiewicz, MD, PhD, Director, Brander Cancer Research Institute, Valhalla, NY

09.30 – 10.00

Advanced Cell Cycle Analysis – James Jacobberger, PhD, Professor of Oncology, Case Western Reserve University, and Director, Cell Analysis Core, Case Comprehensive Cancer Center, Cleveland OH

10.00 – 10.15

Break

10.15 – 10.45

The Untapped Potential of Laser Scanning Cytometry in Genome Damage, Proteome and Nutritional Diagnostics at the Single Cell and Sub-Type Level - Michael Fenech, PhD, Principal Research Scientist, CSIRO Food and Nutrition Sciences, Commonwealth Scientific and Industrial Research Organisation, Adelaide, Australia

10.45 – 11.15

Potential Mechanisms for the Generation of Chromosome Aneuploidy in Human Cancer -
John M. Lehman, PhD, Brody School of Medicine, East Carolina University, Greenville, NC

11.15 – 11.45

Practical Apoptosis Assays Using the iCyte Platform - Stephan Ruetz, PhD, Laboratory Head, Oncology Research, Novartis Institute for Biomedical Research, Basel, Switzerland

11.45 – 12.00

Discussion

Thursday, August 12, 2010

Pharmacodynamic and Diagnostic Tissue-Based Biomarkers

Jimmy Fund Auditorium, Dana-Farber Cancer Center

Chair: Shazib Pervaiz, National University of Singapore and Duke-NUS GMS

09.00 –  9.30

Application of Imaging Cytometry to the Molecular Therapeutics of Human Solid Tumors -
David Hedley, MD, Senior Scientist, Senior Scientist, Division of Applied Molecular Oncology,
Ontario Cancer Institute, University Health Network, Toronto, ON, Canada

09.30 – 10.00

Leveraging Quantitative Imaging Cytometry to Measure the Pharmacodynamic Impact of Drugs in Development - Gloria Juan, PhD, Principal Scientist, Clinical Immunology, Amgen, Thousand Oaks, CA

10.00 – 10.15

Break

10.00 – 10.45

Quantitative Imaging Cytometry for the Diagnostic Pathologist:  What Does the Laser Scatter Imaging Component Add? - William Geddie, MD, Cytopathologist, University Health Network/Toronto General Hospital, Toronto ON, Canada

10.00 – 11.15

Mislocation of APAFI as a Novel Diagnostic and Prognostic Marker for Refractory Diffuse B-Cell Lymphoma? - Shazib Pervaiz, National University of Singapore and Duke-NUS GMS

10.00 – 11.45

Capturing Signaling Events in the Immune System in Situ - Margaret Harnett, PhD, Glasgow Biomedical Research Centre, University of Glasgow, Scotland, UK

10.00 – 12.00

Discussion

AFTERNOON WORKSHOPS

Karp and CLSB Buildings, Children's Hospital Boston

Participants will have their choice of three of the workshops listed below

Workshop I

Cytome Diagnostics

Wayne Leifert, PhD and Maxime Francois, CSIRO Food and Nutrition Sciences

Adelaide, Australia

Workshop II

Quantitative Assessment of Pancreatic Islets

David Krull, GlaxoSmithKline

Research Triangle Park, NC

Workshop III

Advanced Cell Cycle Analysis

James Jacobberger, PhD and  Tammy Stefan

Case Comprehensive Cancer Center, Cleveland, OH

Workshop IV

Immunophenotyping in FNAs (fine needle aspirates)

William Geddie, MD, UHN/Toronto General Hospital

Toronto, ON, Canada

Workshop V

Analysis of Drug-Induced DNA Damage

Zbigniew Darzynkiewicz, MD, PhD, Director, Brander Cancer Research Institute, New York

Medical College, Valhalla, NY and Shazib Pervaiz, National University of Singapore and

Duke-NUS GMS

Workshop VI

Quantitative Imaging of Bone Marrow Microenvironment

C้sar Nombela-Arrieta, PhD and Shin-Young Park, PhD

Children’s Hospital Boston, Boston, MA

Evenings provide a relaxed setting for socializing. The opening reception and poster session will be held on Tuesday, August 10 at 5:30, in the Karp Family Research Building (10th Floor Atrium). 

Information about getting to Boston, accommodations for the meeting, and the things to see and do in the area is available here.

REGISTRATION  and DEADLINES

Registration for full program ends July 20, 2010

Registration for mornings only ends August 5, 2010

Call for short oral and poster presentations:

Short oral presentations: March 10, 2010

Poster Presentation: Deadline July 20, 2010